5-hydroxytryptamine and neurotransmitter release in canine blood vessels. Inhibition by low and augmentation by high concentrations

Circulation Research
M A McGrath

Abstract

No abstract listed.

References

Mar 1, 1975·The Journal of Physiology·R R Lorenz, P M Vanhoutte
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·S Pluchino
Mar 11, 1968·The American Journal of Physiology·R M DaughertyF J Haddy
Oct 1, 1968·The Australian Journal of Experimental Biology and Medical Science·G C Scroop, J A Walsh
Feb 1, 1974·European Journal of Pharmacology·H Ozawa, T Katsuragi
Feb 1, 1972·The American Journal of Physiology·B M AlturaL R Orkin
Jul 1, 1974·Biochemical Pharmacology·S Z Langer
Apr 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·T E EmersonR M Daugherty
Jun 1, 1974·Canadian Journal of Physiology and Pharmacology·R J Reiffenstein, C R Triggle
Jul 1, 1972·Microvascular Research·H R Maricq
Mar 1, 1969·British Journal of Pharmacology·S Kalsner, M Nickerson
Aug 1, 1967·British Journal of Pharmacology and Chemotherapy·J A Walsh
Jul 1, 1953·Circulation Research·I H PAGE, J W MCCUBBIN
Dec 1, 1953·British Journal of Pharmacology and Chemotherapy·W FELDBERG, A N SMITH
Dec 1, 1957·British Journal of Pharmacology and Chemotherapy·W E GLOVERR F WHELAN
Dec 1, 1966·British Journal of Pharmacology and Chemotherapy·I S De La LandeJ G Waterson

❮ Previous
Next ❯

Citations

Dec 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·P Elliott, D I Wallis
Mar 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·A D MedhurstA J Kaumann
Nov 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·A T Sullivan, G M Drew
Aug 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·P R SaxenaJ Heiligers
Apr 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·M GöthertH R Zerkowski
Oct 16, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·K Starke, R Weitzell
Jan 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·F BrandãoJ G Monteiro
May 19, 1989·European Journal of Pharmacology·G J MolderingsE Schlicker
Mar 19, 1984·Life Sciences·F R WilmothF N Miller
Aug 1, 1996·Journal of Clinical Anesthesia·L Gyermek
Aug 24, 1999·Neurochemistry International·P Sándor
Jan 22, 2013·ACS Chemical Neuroscience·Ewan J Mylecharane
Sep 1, 1983·Clinical and Experimental Pharmacology & Physiology·T Kimura, S Satoh
Sep 1, 1984·Clinical and Experimental Pharmacology & Physiology·J F Marwood, G S Stokes
Jul 1, 1991·Clinical and Experimental Pharmacology & Physiology·K Tsuda, Y Masuyama
Oct 1, 1979·British Journal of Pharmacology·W FeniukA D Watts
Dec 1, 1991·British Journal of Pharmacology·S TadipatriP R Saxena
Mar 1, 1992·Pacing and Clinical Electrophysiology : PACE·K YanoY Matsumoto
Dec 1, 1995·Pacing and Clinical Electrophysiology : PACE·G J Fahy, R G Trohman
Oct 24, 1998·Journal of Cardiovascular Electrophysiology·T Satoh, D P Zipes
Jun 4, 1999·Journal of Cardiovascular Electrophysiology·S M MarkowitzB B Lerman
Oct 6, 2000·Journal of Cardiovascular Electrophysiology·O F SharifovJ P Boineau
Mar 10, 2000·Journal of Cardiovascular Electrophysiology·S A ChenM S Chang
Dec 1, 1979·The Journal of Pharmacy and Pharmacology·J MarinC F Sánchez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.